New $13 million center tackles diabetes disparities with community-driven research

Roughly 11 percent of people living in the United States have type 2 diabetes and nearly 40 percent of adults have prediabetes, according to the Centers for Disease Control and Prevention.

Ocaliva’s Takedown by FDA Panel

Without sufficient data to work with, FDA advisors were strongly inclined against giving full approval of obeticholic acid (Ocaliva or OCA) in primary biliary cholangitis

September 14, 2024

Otsuka’s ADHD asset succeeds in registrational trials with children and teens

Otsuka Pharmaceutical’s ADHD drug candidate has met its goal in a pair of Phase III trials focused on children and teens with the neurodevelopmental condition,

October 28, 2023

Fasting-mimicking diet shows unique benefits in cardiovascular health, study finds

Study compares the fasting-mimicking diet and the Mediterranean diet in reducing cardiovascular disease risk among obese adults with hypertension, revealing unique benefits of each diet.

December 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.